The EQ Score shows the company's activity and appeal on the platform: profile completeness, news, likes, follows, membership in one or more labels or communities, number of members in its network, etc.
Aquilon Pharma is a multidisciplinary PharmaTech company with global ambitions, engaged in improving the efficacy of existing inhaled drugs/making drug inhalable, thanks to its breakthrough functional recipient technology.
Liège, Région wallonne, Belgium
Send a message
Start in Octobre, 2013
Aquilon Pharma was incorporated in as a spin-off from ULiège (now independent).
One year later, a first preclinical POC was developed and 8 patents were submitted (WO).
2015 - 2016
The initial laboratory formulation was turned into a stable formulation. Toxicology testing began.
Aquilon Pharma has successfully raised 6.75M€ to support clinical phase I/IIa of 2 first products.
Aquilon Pharma has developed a fully integrated team with 12 people supported by 4 senior executives
to be continued ...